12 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation ... #Pain #Pharmacology ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... Distribution, Agents ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Doses #Dosing
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... Preferred first agent ... #Summary #management ... #medications
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
• Tx: Reduce dose ... greatest risk • Tx: Dose ... Extreme rigidity, fever ... #SideEffects #pharmacology ... #management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... Pain Management ... in CKD, <2g in liver ... Table #Ladder #medications ... #pharmacology #
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
tool to assess level ... non-OTC prolonging agent ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
Gout - Diagnosis and Management Summary

3 Conditions for Gout to Manifest:
1. Hyperuricemia
2. Monosodium urate deposition in
Diagnosis and Management ... Summary 3 Conditions ... Metabolic syndrome • Medications ... NSAIDs • Low-dose ... Concomitant low-dose